Development of plasmin and plasma kallikrein selective inhibitors and their effect on M1 (melanoma) and ht29 cell lines - Concepedia

Concepedia

Publication | Open Access

Development of plasmin and plasma kallikrein selective inhibitors and their effect on M1 (melanoma) and ht29 cell lines

DOI Full Paper Access

13

Citations

9

References

2000

Year

Yoshio Okada, Yuko Tsuda, Keiko Wanaka, Mayako Tada, U Okamoto, Shosuke Okamoto, Akiko Hijikata‐Okunomiya, Györgyi Bökönyi, Béla Szende, Gÿorgý Kéri

Bioorganic & Medicinal Chemistry Letters

MedicineCell LinesImmune Checkpoint InhibitorTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyTumor MicroenvironmentCancer ResearchDrug Discovery

References

	Year	Citations

Page 1

Page 1